A composition comprising: a) recombinant exosporium-producing Bacillus cells of a Bacillus cereus family member that express a fusion protein comprising: (i) at least one protein or peptide selected from the group consisting of an endoglucanase having at least 85% sequence identity to SEQ ID NO:107, and a phospholipase having at last 85% sequence identity to SEQ ID NO:108; and (ii) a targeting sequence, an exosporium protein or an exosporium protein fragment; wherein the targeting sequence, exosporium protein, or exosporium protein fragment comprises: - an amino acid sequence having at least 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least 90%; or - amino acids 1-35 of SEQ ID NO:1; or - amino acids 20-35 of SEQ ID NO:1; or - amino acids 22-31 of SEQ ID NO:1; or - amino acids 22-33 of SEQ ID NO:1; or - amino acids 20-31 of SEQ ID NO:1; or - the amino acid sequence of SEQ ID NO:1; or - an amino acid sequence having at least 85% identity with SEQ ID NO:2; and b) at least one biological control agent selected from the group consisting of Bacillus subtilis QST713 and Bacillus firmus I-1582, in a synergistically effective amount, wherein said synergism refers to the effect of enhancing plant growth. a) recombinant exosporium-producing Bacillus cells of a Bacillus cereus family member that express a fusion protein comprising: (i) at least one protein or peptide selected from the group consisting of an endoglucanase having at least 85% sequence identity to SEQ ID NO:107, and a phospholipase having at last 85% sequence identity to SEQ ID NO:108; and (ii) a targeting sequence, an exosporium protein or an exosporium protein fragment; wherein the targeting sequence, exosporium protein, or exosporium protein fragment comprises: - an amino acid sequence having at least 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least 90%; or - amino acids 1-35 of SEQ ID NO:1; or - amino acids 20-35 of SEQ ID NO:1; or - amino acids 22-31 of SEQ ID NO:1; or - amino acids 22-33 of SEQ ID NO:1; or - amino acids 20-31 of SEQ ID NO:1; or - the amino acid sequence of SEQ ID NO:1; or - an amino acid sequence having at least 85% identity with SEQ ID NO:2; and (i) at least one protein or peptide selected from the group consisting of an endoglucanase having at least 85% sequence identity to SEQ ID NO:107, and a phospholipase having at last 85% sequence identity to SEQ ID NO:108; and (ii) a targeting sequence, an exosporium protein or an exosporium protein fragment; wherein the targeting sequence, exosporium protein, or exosporium protein fragment comprises: - an amino acid sequence having at least 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least 90%; or - amino acids 1-35 of SEQ ID NO:1; or - amino acids 20-35 of SEQ ID NO:1; or - amino acids 22-31 of SEQ ID NO:1; or - amino acids 22-33 of SEQ ID NO:1; or - amino acids 20-31 of SEQ ID NO:1; or - the amino acid sequence of SEQ ID NO:1; or - an amino acid sequence having at least 85% identity with SEQ ID NO:2; and - an amino acid sequence having at least 81% identity with amino acids 20-35 of SEQ ID NO:1, wherein the identity with amino acids 25-35 is at least 90%; or - amino acids 1-35 of SEQ ID NO:1; or - amino acids 20-35 of SEQ ID NO:1; or - amino acids 22-31 of SEQ ID NO:1; or - amino acids 22-33 of SEQ ID NO:1; or - amino acids 20-31 of SEQ ID NO:1; or - the amino acid sequence of SEQ ID NO:1; or - an amino acid sequence having at least 85% identity with SEQ ID NO:2; and b) at least one biological control agent selected from the group consisting of Bacillus subtilis QST713 and Bacillus firmus I-1582,